Piramal Pharma Limited (PPL), a subsidiary of Piramal Enterprises Limited (PEL), announced that it has received INR 3523.40 Crores on closure of the transaction for 20% equity investment from CA Alchemy Investments (formerly known as CA Clover Intermediate II Investments), an affiliated entity of CAP V Mauritius Limited, an investment fund managed and advised by…